Efficacy
cSCC, cSCC lesions
The mean time of historical dermatological follow-up before inclusion in the study was 69 ± 58 months in the SRL group versus 70 ± 56 months in the CNI group (p = 0.956). At baseline (T0), the incidence density of cSCC was 1.49 lesions/patient-year in the SRL group versus 1.74 lesions/patient-year in the CNI group (p = 0.949).When analyzing the behavior of all cSCC lesions as a collective, especially from visit T2 on, there was a trend of decreasing incidence densities in the SRL group and a trend of increasing incidence densities in the CNI group over time (p = 0.141; 